As part of its annual meeting deliberations this week, the American Medical Association (AMA) reaffirmed its concern about youths' use of electronic cigarettes and clarified its support of restrictions on the marketing of the products.
A new policy adopted at the annual meeting states the AMA's opposition to the sale and marketing of e-cigarettes to minors. It also supports a number of other restrictions, including limits on product flavors that appeal to underage consumers; disclosure of product content and emissions; and a ban on unsubstantiated marketing claims about the devices' potential in smoking cessation.
“The AMA supports [a Food and Drug Administration] proposal to fill the gap in federal regulations on purchasing, labeling, packaging and advertising of electronic cigarettes,” incoming AMA President Robert M. Wah, MD, said in a news release.
Health professionals have become increasingly concerned that the reality of e-cigarettes' effects appears far less promising than what makers of the devices have touted, as evidenced by findings of a recent review of the most comprehensive clinical trials conducted so far.